Co-Authors
This is a "connection" page, showing publications co-authored by Jenny Low and Eng Ooi.
Connection Strength
3.603
-
Asymptomatic SARS-CoV-2 infection. Lancet Infect Dis. 2020 09; 20(9):996-998.
Score: 0.887
-
Prognosticating Dengue. Clin Infect Dis. 2017 03 01; 64(5):664-665.
Score: 0.706
-
Dengue--old disease, new challenges in an ageing population. Ann Acad Med Singap. 2013 Aug; 42(8):373-5.
Score: 0.551
-
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice. Mol Ther. 2021 06 02; 29(6):1970-1983.
Score: 0.235
-
A Dynamic Immune Response Shapes COVID-19 Progression. Cell Host Microbe. 2020 06 10; 27(6):879-882.e2.
Score: 0.220
-
Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection. Nat Med. 2019 08; 25(8):1218-1224.
Score: 0.208
-
Early molecular correlates of adverse events following yellow fever vaccination. JCI Insight. 2017 10 05; 2(19).
Score: 0.184
-
A Report of Adult Human Adenovirus Infections in a Tertiary Hospital. Open Forum Infect Dis. 2017; 4(2):ofx053.
Score: 0.177
-
Current Status of Dengue Therapeutics Research and Development. J Infect Dis. 2017 Mar 01; 215(suppl_2):S96-S102.
Score: 0.177
-
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution. EBioMedicine. 2021 Mar; 65:103262.
Score: 0.058
-
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020 08; 584(7821):457-462.
Score: 0.056
-
Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity. NPJ Vaccines. 2019; 4:27.
Score: 0.052
-
Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. Sci Adv. 2018 07; 4(7):eaar4297.
Score: 0.048
-
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017 04 22; 389(10079):1611-1618.
Score: 0.044